BSX Q1 2019 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q1 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.5B+4.8% YoY

Gross Profit

$1.6B63.9% margin

Operating Income

$429M17.2% margin

Net Income

$424M17.0% margin

EPS (Diluted)

$0.30

QoQ Revenue Growth

-2.7%

Cash Flow

Operating Cash Flow

$350M

Free Cash Flow

$259M

Stock-Based Comp.

$36M

Balance Sheet

Total Assets

$23.8B

Total Liabilities

$14.6B

Stockholders' Equity

$9.2B

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.5B	$2.4B	+4.8%
Gross Profit	$1.6B	$1.6B	+0.4%
Operating Income	$429M	$457M	-6.1%
Net Income	$424M	$298M	+42.3%

Revenue Segments

Cardiovascular

$972M56%

MedSurg

$766M44%

Geographic Segments

UNITED STATES

$1.4B56%

Non-US

$1.1B44%